CLS Partners With advanced fiber tools to Explore New Medical Laser Markets

By Public Technologies
  • CLS entered a strategic partnership with advanced fiber tools to develop medical laser products for markets beyond neurosurgery and urology.
  • The collaboration combines CLS's uncooled laser technology with its partner's fiber-optic development and manufacturing expertise.
  • The nonexclusive agreement entails no immediate financial commitments or guaranteed commercial volumes; individual projects require separate agreements.
  • Existing manufacturing agreements remain unchanged.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CLS - Clinical Laserthermia Systems AB published the original content used to generate this news brief via Cision (Ref. ID: 202611190230BITN____UKPR__SV_20261118-BIT-1297-0) on November 19, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.